United Therapeutics (UTHR) Interest Coverage Ratio (2009 - 2026)

United Therapeutics has disclosed Interest Coverage Ratio across 18 years of filings, most recently posting 108.6 for Q1 2026.

• Interest Coverage Ratio for Q1 2026 came in at 108.6, up 73.06% year-over-year; the trailing twelve-month figure through Mar 2026 was 87.53 (up 122.65% YoY), and the FY2025 annual result was 76.54, up 138.45% from the prior year.
• Interest Coverage Ratio came in at 108.6 for Q1 2026 at United Therapeutics, down from 115.06 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 129.5 in Q3 2025 to a low of 14.28 in Q4 2022.
• The 5-year median for Interest Coverage Ratio is 33.97 (2024), against an average of 48.34.
• Across the five-year window, Interest Coverage Ratio soared 534.99% in 2022 and sank 66.37% in 2023, its largest moves.
• United Therapeutics' Interest Coverage Ratio stood at 14.28 in 2022, then grew by 20.65% to 17.23 in 2023, then soared by 162.86% to 45.28 in 2024, then surged by 154.13% to 115.06 in 2025, then decreased by 5.62% to 108.6 in 2026.
• The last three Interest Coverage Ratio figures came in at 108.6 (Q1 2026), 115.06 (Q4 2025), and 129.5 (Q3 2025), per Business Quant data.